Study Using the SpinalStim Device Following Lumbar Fusion Surgery
A Multi-Center, Open-Label, Prospective Study of SpinalStim™ (MOP-SS) as Adjunctive Care Following Lumbar Fusion Surgery
Sponsor: Orthofix Inc.
Listed as NCT03176303, this observational or N/A phase trial focuses on Lumbar Spine Degeneration and remains completed. Sponsored by Orthofix Inc., it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2021 — Sep 2022 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Unknown Status
▶ Show 5 earlier versions
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Enrolling By Invitation
-
Apr 2018 — Jun 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Jul 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Orthofix Inc.
For direct contact, visit the study record on ClinicalTrials.gov .